Cetera Investment Advisers’s Bristol-Myers Squibb BMY Stock Holding History

Cetera Investment Advisers’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$305	Hold	100	–	–	﹤0.01%	4993
2026 Q1	$315	Hold	100	–	–	﹤0.01%	4777
2025 Q4	$2	Buy	+100	New	+$4.81K	﹤0.01%	4684
2025 Q1	–	Sell	-2,600	Closed	-$3.67K	–	3988
2024 Q4	$3.67K	Buy	+2,600	New	+$145K	﹤0.01%	3746
2023 Q2	–	Sell	-100	Closed	-$111	–	2209
2023 Q1	$111	Hold	100	–	–	﹤0.01%	2162
2022 Q4	$205	Buy	+100	New	+$7.54K	﹤0.01%	2104

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Cetera Investment Advisers's BMY Position: Q2 2026 in Review

Cetera Investment Advisers increased its Bristol-Myers Squibb (BMY) stake by 7.4% in Q2 2026, buying an estimated $3.5M and bringing the position to 883,910 shares worth $50.9M. The position accounts for 0.05% of the portfolio, ranked #402.

Cetera Investment Advisers first reported a position in BMY in Q4 2015 and has held it in 43 quarters since. 2,523 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Cetera Investment Advisers held 883,910 shares of Bristol-Myers Squibb worth $50.9M as of Q2 2026.
Cetera Investment Advisers bought 60,962 Bristol-Myers Squibb shares in Q2 2026, an estimated $3.5M.
Bristol-Myers Squibb made up 0.05% of Cetera Investment Advisers's portfolio in Q2 2026, its #402 holding.
Cetera Investment Advisers first reported a position in Bristol-Myers Squibb in Q4 2015 and has held it in 43 quarters since.
2,523 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.